A participant in the NIH 2019-2020 Medical Research Scholars Program.
Photo Credit: National Institutes of Health
About This Photo
Prior treatment with cancer drug likely renders COVID-19 vaccine ineffective, study finds
People who have been treated with rituximab, a widely used cancer drug, or similar drugs respond poorly or not at all to subsequent COVID-19 mRNA vaccines, according to a study by researchers at Stanford Medicine.